跳至主要内容
临床试验/NL-OMON24672
NL-OMON24672尚未招募不适用

Examining the pharmacokinetic and pharmacodynamic profile of biperiden

Maastricht University0 个研究点目标入组 27 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
27

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • In the opinion of the investigator, the participant is capable of understanding and complying with protocol requirements.
  • The participant has a body mass index of 18.5-30 kg/m2, inclusive, at medical screening.

排除标准

  • The subject has uncontrolled, clinically significant neurologic, cardiovascular, pulmonary, hepatic, renal, metabolic, gastrointestinal, or endocrine disease or other abnormality which may impact the ability of the subject to participate or potentially confound the study results.
  • The volunteer has uncontrolled existing major psychiatric symptoms.

研究者

相似试验

Examining the pharmacokinetic and pharmacodynamic... | 临床试验